David Martínez‐Cuadrón
David Martínez‐Cuadrón publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #2,898,922 of 7,710,434 ranked researchers
- Rank in Spain
- #64,319 of 204,306
- Works
- 205
- Citations
- 2.1k
- Citations per work
- 10.3
What does David Martínez‐Cuadrón research?
David Martínez‐Cuadrón's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15173.6%
- Medicine15173.6%
- Life Sciences3416.7%
- Everything else209.7%
- 1Hematology49% of their works
- 2Molecular Biology14% of their works
- 3Genetics11% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5Oncology6% of their works
- 6Cancer Research3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Histone Deacetylase Inhibitors Research
- Cancer Genomics and Diagnostics
Which keywords describe David Martínez‐Cuadrón's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, JAK2 Mutation, Myelofibrosis and BCR-ABL.
- Cancer Genomics
- HDAC Inhibitors
- Bone Marrow Niche
- Diagnosis Criteria
- Acute Lymphoblastic Leukemia
- BCR-ABL
- JAK2 Mutation
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Minimal Residual Disease
- Myelofibrosis
- Imatinib
- Childhood Cancer
- International Myeloma Working Group
- Graft-versus-Host Disease
- Histone Deacetylases
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors2122 topics
- Hematopoietic Stem Cells1982 topics
- AML1721 topic
- Acute Myeloid Leukemia1721 topic
- Minimal Residual Disease762 topics
- JAK2 Mutation471 topic
- Myelofibrosis471 topic
- BCR-ABL451 topic
- Imatinib451 topic
- Acute Lymphoblastic Leukemia401 topic
- Childhood Cancer401 topic
- Diagnosis Criteria361 topic
- International Myeloma Working Group361 topic
- Bone Marrow Niche261 topic
- Graft-versus-Host Disease261 topic
- HDAC Inhibitors211 topic
- Histone Deacetylases211 topic
- Cancer Genomics171 topic
- Mutational Signatures171 topic
Where does David Martínez‐Cuadrón work?
David Martínez‐Cuadrón's main affiliation in the publication record is Hospital Universitari i Politècnic La Fe, Spain.
How many publications and citations does David Martínez‐Cuadrón have?
OpenAlex counts 205 works and 2,112 citations for David Martínez‐Cuadrón, an h-index of 27, ranking #2,898,922 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Martínez‐Cuadrón. Posts are plain text and can be reported.